Midatlantic Epilepsy and Sleep Center
Bethesda, Maryland 20817-1844
9 studies enrolling now · 56 studies all time
What they study most
Catamenial Epilepsy, Cortical Excitability, Developmental and Epileptic Encephalopathies, Developmental and Epileptic Encephalopathy, Developmental and/or Epileptic Encephalopathies, Dravet Syndrome, Dravet Syndrome (DS), Epilepsies, Partial, Epilepsy, Epilepsy With Partial On-set Seizures, Epilepsy With Simple or Complex Partial Onset Seizures, Epilepsy, Generalized
Studies at this site
- A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures — Recruiting now
- A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS) — Recruiting now
- Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1 — Recruiting now
- A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures — Recruiting now
- AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy — Recruiting now
- A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3) — Recruiting now
- Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults — Recruiting now
- An Open-label Study of XEN1101 in Epilepsy — Enrolling by invitation
- A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE) — Running, not enrolling
- A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE) — Enrolling by invitation
- Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures — Completed
- Cenobamate Open-Label Extension Study for YKP3089C025 — Completed
- A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome — Stopped early
- A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures — Completed
- Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures — Running, not enrolling
- Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures — Completed
- Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy — Completed
- Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy — Completed
- A Study to Investigate JNJ-40411813 in Combination With Levetiracetam or Brivaracetam in Epilepsy — Completed
- A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures — Completed
- Intermediate-Size Expanded Access Protocol (EAP) for LP352 — Available (expanded access)
- A Study of DS-1211b in Individuals With PseudoXanthoma Elasticum — Completed
- Honeycomb: Evaluation of Radiprodil in Children with GRIN-related Disorder — Running, not enrolling
- Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies — Completed
- A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy — Running, not enrolling
- A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut Syndrome — Completed
- Study of EQU-001 for Uncontrolled Focal Onset Seizures — Stopped early
- ENACT: A Study of ENX-101 as Adjunctive Treatment in Patients With Focal Seizures — Withdrawn before enrolling
- Safety, Tolerability, and Exploratory Efficacy of Adjunctive EQU-001 for Seizures in Adults With Epilepsy — Status unconfirmed
- A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures — Completed
- Open-label Extension to Protocol 1042-0600 — Completed
- Ketogenic Diet as Adjunctive Treatment in Refractory/End-stage Glioblastoma Multiforme: a Pilot Study — Completed
- A Study of Lu AG06466 in Participants With Treatment Resistant Focal Epilepsy — Stopped early
- Cortical Excitability in Post-traumatic Epilepsy — Status unconfirmed
- Prospective Open-label Evaluation of Cenobamate Adjunctive Treatment of Adults With Refractory Focal Epilepsy — Status unconfirmed
- Ketogenic Diet Treatment Adjunctive to Radiation and Chemotherapy in Glioblastoma Multiforme: a Pilot Study — Completed
- Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures — Completed
- Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures — Completed
- Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome — Stopped early
- The Human Epilepsy Project — Completed
- Study of TAK-935 as an Adjunctive Therapy in Participants With Developmental and/or Epileptic Encephalopathies — Completed
- Study of Diazepam Buccal Film Administered in the Interictal and in the Ictal-Periictal States to Adults With Epilepsy — Completed
- Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial — Completed
- A Study of a Drug to be Used in Addition With Another Drug to Treat Adults With Uncontrolled Partial-onset Seizures — Completed
- Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures — Completed
- Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy — Completed
- Eslicarbazepine Acetate Monotherapy Long Term Study — Completed
- Efficacy and Safety of Ketogenic Diet as Adjunctive Treatment in Adults With Refractory Epilepsy — Status unconfirmed
- Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy — Completed
- Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus — Withdrawn before enrolling